Login Register Cart 0
Generic placeholder image

Central Nervous System Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5249
ISSN (Online): 1875-6166

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Behavioral Pharmacology of Five Uncommon Passiflora Species Indicates Sedative and Anxiolytic-like Potential

Author(s): Marna Eliana Sakalem*, Ricardo Tabach, Miriane de Oliveira and Elisaldo Araújo Carlini

Volume 22, Issue 2, 2022

Published on: 21 June, 2022

Page: [125 - 138] Pages: 14

DOI: 10.2174/1871524922666220426102650

Price: $65

Abstract

Background: There are over 500 species in the Passiflora genus, and while some of them are very well known in folk medicine for their anxiolytic effects, very little is known for the other genus representants, which could also present medicinal effects.

Objective: In this study, we performed an interspecific pharmacological comparison of five investigated Passiflora species, all native to Brazil, namely P. bahiensis, P. coccinea, P. quadrangularis, P. sidaefolia, and P. vitifolia.

Methods: Extracts were administered to mice before behavioral testing, including a general pharmacological screening and anxiolytic-like effect investigation.

Results: Three of the species (P. coccinea, P. quadrangularis, and P. sidaefolia) induced a decrease in locomotor activity of mice; P. coccinea also reduced the latency to sleep. Importantly, none of the species interfered with motor coordination. Oral administration evoked no severe signs of toxicity, even at higher doses. Regarding the anxiolytic-like profile, P. sidaefolia reduced the anxious-like behavior in the Holeboard test in a similar way to the positive control, Passiflora incarnata, while not affecting total motricity.

Conclusion: These results indicated that P. coccinea, P. quadrangularis, and P. sidaefolia reduced the general activity of mice and conferred a calmative/sedative potential to these three species, which must be further elucidated by future investigations.

Keywords: Passifloreaceae, maracuja, passionflower, hole-board, pharmacological screening, phytomedicine, medicinal plants, anxiolytic-like effect.

« Previous Next »
Graphical Abstract

[1]
Lépine, J.P. The epidemiology of anxiety disorders: Prevalence and societal costs. J. Clin. Psychiatry, 2002, 63(Suppl. 14), 4-8.
[2]
Akkol, E.K.; Ilhan, M.; Karpuz, B.; Genç, Y.; Sobarzo-Sánchez, E. Sedative and Anxiolytic Activities of Opuntia ficus indica (L.) Mill.: An experimental assessment in mice. Molecules, 2020, 25(8), 1844.
[http://dx.doi.org/10.3390/molecules25081844] [PMID: 32316321]
[3]
Orlandi, P.; Noto, A.R. Uso indevido de benzodiazepínicos: Um estudo com informantes-chave no município de São Paulo. Rev. Lat. Am. Enfermagem, 2005, 13(Spec No), 896-902.
[http://dx.doi.org/10.1590/S0104-11692005000700018] [PMID: 16400457]
[4]
Parviainen, I.; Kälviäinen, R.; Ruokonen, E. Propofol and barbiturates for the anesthesia of refractory convulsive status epilepticus: Pros and cons. Neurol. Res., 2007, 29(7), 667-671.
[http://dx.doi.org/10.1179/016164107X240044] [PMID: 18173905]
[5]
Carlini, E.A. Plants and the central nervous system. Pharmacol. Biochem. Behav., 2003, 75(3), 501-512.
[http://dx.doi.org/10.1016/S0091-3057(03)00112-6] [PMID: 12895668]
[6]
Epstein, H.A. A natural approach to soothing atopic skin. Skinmed, 2010, 8(2), 95-97.
[PMID: 20527141]
[7]
Lemos, R.C.C.; da Costa Silva, D. Flavia de Albuquerque Melo-de-Pinna, G. A structural review of foliar glands in Passiflora L. (Passifloraceae). PLoS One, 2017, 12(11), e0187905.
[http://dx.doi.org/10.1371/journal.pone.0187905] [PMID: 29136029]
[8]
Cervi, A.C.; Imig, D.C. A new species of Passiflora (Passifloraceae) from Mato Grosso do Sul, Brazil. Phytotaxa, 2013, 103(1), 46-50.
[http://dx.doi.org/10.11646/phytotaxa.103.1.3]
[9]
He, X.; Luan, F.; Yang, Y.; Wang, Z.; Zhao, Z.; Fang, J.; Wang, M.; Zuo, M.; Li, Y. Passiflora edulis: An insight into current researches on phytochemistry and pharmacology. Front. Pharmacol., 2020, 11, 617.
[http://dx.doi.org/10.3389/fphar.2020.00617] [PMID: 32508631]
[10]
Krenn, L. Passion Flower (Passiflora incarnata L.)-a reliable herbal sedative. Wien. Med. Wochenschr., 2002, 152(15-16), 404-406.
[http://dx.doi.org/10.1046/j.1563-258X.2002.02062.x] [PMID: 12244887]
[11]
da Fonseca, L.R.; Rodrigues, R.A.; Ramos, A.S.; da Cruz, J.D.; Ferreira, J.L.P.; Silva, J.R.A.; Amaral, A.C.F. Herbal medicinal products from Passiflora for anxiety: An unexploited potential. ScientificWorldJournal, 2020, 2020, 6598434.
[http://dx.doi.org/10.1155/2020/6598434] [PMID: 32765195]
[12]
Franco, S.L. Maytenus ilicifolia Martius ex. Reiss. Celastraceae - Proposta tecnológica de macerados; Universidade Federal do Rio Grande do Sul, 1990.
[13]
Sakalem, ME; Negri, G; Tabach, R Chemical composition of hydroethanolic extracts from five species of the Passiflora genus. Brazilian J Pharmacogn 2012, 22(6)
[http://dx.doi.org/10.1590/S0102-695X2012005000108]
[14]
Tveden-Nyborg, P.; Bergmann, T.K.; Jessen, N.; Simonsen, U.; Lykkesfeldt, J. BCPT policy for experimental and clinical studies. Basic Clin. Pharmacol. Toxicol., 2021, 128(1), 4-8.
[http://dx.doi.org/10.1111/bcpt.13492] [PMID: 32955760]
[15]
McGrath, J.C.; Drummond, G.B.; McLachlan, E.M.; Kilkenny, C.; Wainwright, C.L. Guidelines for reporting experiments involving animals: The ARRIVE guidelines. Br. J. Pharmacol., 2010, 160(7), 1573-1576.
[http://dx.doi.org/10.1111/j.1476-5381.2010.00873.x] [PMID: 20649560]
[16]
Carlini, E.A. Screening farmacológico de plantas brasileiras. Rev. Bras. Biol., 1972, 32(2), 265-274.
[PMID: 4651868]
[17]
Carlini, E.A.; Burgos, V. Screening farmacológico de ansiolíticos: Metodologia laboratorial e comparacao entre diazepam e clorobenzepam. Rev Assoc Bras Psiquiatr., 1979, 1(1), 25-31.
[18]
Tabach, R.; Rodrigues, E.; Carlini, E.A. Preclinical toxicological assessment of a phytotherapeutic product--CPV (based on dry extracts of Crataegus oxyacantha L., Passiflora incarnata L., and Valeriana officinalis L.). Phytother. Res., 2009, 23(1), 33-40.
[http://dx.doi.org/10.1002/ptr.2499] [PMID: 19048610]
[19]
Molska, G.; Paula-Freire, L.I.; Sakalem, M.E.; Köln, D.; Negri, G.; Carlini, E.A. Green coffee extract attenuates Parkinson’s-related behaviors in animal models. Ann Brazilian Acad Sci, 2021, 93(4), e202-e10481.
[20]
Tabach, R.; Mattei, R.; Carlini, E.L de A. Pharmacological evaluation of a phytotherapeutic product - CPV (dry extract of Crataegus oxyacantha L., Passiflora incarnata L. and Valeriana officinalis L.) in laboratory animals. Rev. Bras. Farmacogn., 2009, 19(1b), 255-260.
[http://dx.doi.org/10.1590/S0102-695X2009000200013]
[21]
Carlini, E.A. Contar J de, D.P.; Silva-Filho, A.R.; da Silveira-Filho, N.G.; Frochtengarten, M.L.; Bueno, O.F. Pharmacology of lemongrass (Cymbopogon citratus Stapf). I. Effects of teas prepared from the leaves on laboratory animals. J. Ethnopharmacol., 1986, 17(1), 37-64.
[http://dx.doi.org/10.1016/0378-8741(86)90072-3] [PMID: 3762195]
[22]
Hodgson, E. Dose-response relationships.Levi, PE Textbook of modern toxicology, 2nd ed; Hodgson, E., Ed.; McGraw-Hill Companies: Singapore, 2000, pp. 1-25.
[23]
Hilakivi, L.A.; Ota, M.; Lister, R.G. Effect of isolation on brain monoamines and the behavior of mice in tests of exploration, locomotion, anxiety and behavioral ‘despair’. Pharmacol. Biochem. Behav., 1989, 33(2), 371-374.
[http://dx.doi.org/10.1016/0091-3057(89)90516-9] [PMID: 2479036]
[24]
Hansen, R.T., III; Conti, M.; Zhang, H.T. Mice deficient in phosphodiesterase-4A display anxiogenic-like behavior. Psychopharmacology (Berl.), 2014, 231(15), 2941-2954.
[http://dx.doi.org/10.1007/s00213-014-3480-y] [PMID: 24563185]
[25]
Noschang, C.; Krolow, R.; Arcego, D.M.; Marcolin, M.; Ferreira, A.G.; da Cunha, A.A.; Wyse, A.T.S.; Dalmaz, C. Early-life stress affects behavioral and neurochemical parameters differently in male and female juvenile Wistar rats. Int. J. Dev. Neurosci., 2020, 80(6), 547-557.
[http://dx.doi.org/10.1002/jdn.10050] [PMID: 32683715]
[26]
Selvan, A.; Suresh, R. Antianxiety, anticonvulsant, myorelaxant and hypnotic effect of polyherbal extracts on rodents. Int J Pharmacogn., 2018, 5(8), 509-516.
[27]
MacDougal, J.M.; Feuillet, C. Systematics.Ulmer, T and MacDougal JM, Passiflora: Passionflowers of the world; Timber press: Cambridge, 2004, pp. 27-31.
[28]
Santos, K.C.; Kurtz, S.M.T.F.; Müller, S.D.; Biavatti, M.W.; Oliveira, R.M.M.W. Santos, CAM Sedative and anxiolytic effects of methanolic extract from the leaves of Passiflora actinia. Braz arch Boil technol, 2006, 49(4), 565-573.
[http://dx.doi.org/10.1590/S1516-89132006000500005]
[29]
Boniface, P.K.; Elizabeth, F.I. Flavones as a privileged scaffold in drug discovery: current developments. Curr. Org. Synth., 2019, 16(7), 968-1001.
[http://dx.doi.org/10.2174/1570179416666190719125730] [PMID: 31984880]
[30]
Germán-Ponciano, L.J.; Puga-Olguín, A.; De Jesús Rovirosa-Hernández, M.; Caba, M.; Meza, E.; Rodríguez-Landa, J.F. Differential effects of acute and chronic treatment with the flavonoid chrysin on anxiety-like behavior and Fos immunoreactivity in the lateral septal nucleus in rats. Acta Pharm., 2020, 70(3), 387-397.
[http://dx.doi.org/10.2478/acph-2020-0022] [PMID: 32074069]
[31]
Alves, J.S.F.; Marques, J.I.; Demarque, D.P.; Costa, L.R.F.; Amaral, J.G.; Lopes, N.P.; da Silva-Júnior, A.A.; Soares, L.A.L.; Gavioli, E.C.; Ferreira, L.D.S.; Zucolotto, S.M. Correction to: Involvement of isoorientin in the antidepressant bioactivity of a flavonoid-rich extract from Passiflora edulis f. flavicarpa leaves. Rev. Bras. Farmacogn., 2020, 30(2), 319-319.
[http://dx.doi.org/10.1007/s43450-020-00051-3]
[32]
Wasowski, C.; Marder, M. Flavonoids as GABAA receptor ligands: The whole story? J. Exp. Pharmacol., 2012, 4, 9-24.
[PMID: 27186113]
[33]
Lam, K.Y.; Ling, A.P.K.; Koh, R.Y.; Wong, Y.P.; Say, Y.H. A review on medicinal properties of orientin. Adv. Pharmacol. Sci., 2016, 2016, 4104595.
[http://dx.doi.org/10.1155/2016/4104595] [PMID: 27298620]
[34]
Gazola, A.C.; Costa, G.M.; Castellanos, L.; Ramos, F.A.; Reginatto, F.H.; de Lima, T.C.M. Involvement of GABAergic pathway in the sedative activity of apigenin, the main flavonoid from Passiflora quadrangularis pericarp. Rev. Bras. Farmacogn., 2015, 25(2), 158-163.
[http://dx.doi.org/10.1016/j.bjp.2015.03.009]
[35]
He, M.; Min, J-W.; Kong, W-L.; He, X-H.; Li, J-X.; Peng, B-W. A review on the pharmacological effects of vitexin and isovitexin. Fitoterapia, 2016, 115, 74-85.
[http://dx.doi.org/10.1016/j.fitote.2016.09.011] [PMID: 27693342]
[36]
Uma Devi, P.; Ganasoundari, A.; Vrinda, B.; Srinivasan, K.K.; Unnikrishnan, M.K. Radiation protection by the ocimum flavonoids orientin and vicenin: Mechanisms of action. Radiat. Res., 2000, 154(4), 455-460.
[http://dx.doi.org/10.1667/0033-7587(2000)154[0455:RPBTOF]2.0.CO;2] [PMID: 11023610]
[37]
Marrassini, C.; Davicino, R.; Acevedo, C.; Anesini, C.; Gorzalczany, S.; Ferraro, G. Vicenin-2, a potential anti-inflammatory constituent of Urtica circularis. J. Nat. Prod., 2011, 74(6), 1503-1507.
[http://dx.doi.org/10.1021/np100937e] [PMID: 21608987]
[38]
Saroya, A.S.; Singh, J. Neuropharmacology of Passiflora genus. pharmacotherapeutic potential of natural products in neurological disorders; Springer Singapore: Singapore, 2018, pp. 59-79.
[http://dx.doi.org/10.1007/978-981-13-0289-3_5]
[39]
Figueiredo, D.A.F.; Pordeus, L.C.M.; Paulo, L.L.; Braga, R.M.; Fonsêca, D.V.; Sousa, B.S.; Costa, M.J.C.; Gonçalves, M.C.R.; Oliveira, K.H.D. Effects of bark flour of Passiflora edulis on food intake, body weight and behavioral response of rats. Rev. Bras. Farmacogn., 2016, 26(5), 595-600.
[http://dx.doi.org/10.1016/j.bjp.2016.02.010]
[40]
Lutomski, J.; Malek, B.; Rybacka, L. Pharmacochemical investigations of the raw materials from Passiflora genus. 2. The pharmacochemical estimation of juices from the fruits of Passiflora edulis and Passiflora edulis forma flavicarpa. Planta Med., 1975, 27(2), 112-121.
[http://dx.doi.org/10.1055/s-0028-1097771] [PMID: 1121523]
[41]
Holanda, D.K.R.; Wurlitzer, N.J.; Dionisio, A.P.; Campos, A.R.; Moreira, R.A.; Sousa, P.H.M.; Brito, E.S.; Ribeiro, P.R.V.; Iunes, M.F.; Costa, A.M. Garlic passion fruit (Passiflora tenuifila Killip): Assessment of eventual acute toxicity, anxiolytic, sedative, and anticonvulsant effects using in vivo assays. Food Res. Int., 2020, 128, 108813.
[http://dx.doi.org/10.1016/j.foodres.2019.108813] [PMID: 31955772]
[42]
Soulimani, R.; Younos, C.; Jarmouni, S.; Bousta, D.; Misslin, R.; Mortier, F. Behavioural effects of Passiflora incarnata L. and its indole alkaloid and flavonoid derivatives and maltol in the mouse. J. Ethnopharmacol., 1997, 57(1), 11-20.
[http://dx.doi.org/10.1016/S0378-8741(97)00042-1] [PMID: 9234160]
[43]
Provensi, G.; Noël, F.; Lopes, D.V.S.; Fenner, R.; Betti, A.H.; de Costa, F. Participation of GABA-benzodiazepine receptor complex in the anxiolytic effect of Passiflora alata Curtis (Passifloraceae). Lat. Am. J. Pharm., 2008, 27(6), 845-851.
[44]
Oga, S.; de Freitas, P.C.; Gomes da Silva, A.C.; Hanada, S. Pharmacological trials of crude extract of Passiflora alata. Planta Med., 1984, 50(4), 303-306.
[http://dx.doi.org/10.1055/s-2007-969715] [PMID: 6505080]
[45]
Speroni, E.; Billi, R.; Mercati, V.; Boncompagni, E.; Toja, E. Sedative effects of crude extract of Passiflora incarnata after oral administration. Phytother. Res., 1996, 10, 92-94.
[46]
Deng, J.; Zhou, Y.; Bai, M.; Li, H.; Li, L. Anxiolytic and sedative activities of Passiflora edulis f. flavicarpa. J. Ethnopharmacol., 2010, 128(1), 148-153.
[http://dx.doi.org/10.1016/j.jep.2009.12.043] [PMID: 20051259]
[47]
Maluf, E.; Barros, H.M.T.; Frochtengarten, M.L.; Benti, R.; Leite, J.R. Assessment of the hypnotic sedative effects and toxicity of Passiflora edulis aqueous extract in rodents and humans. Phytother. Res., 1991, 5(6), 262-266.
[http://dx.doi.org/10.1002/ptr.2650050607]
[48]
Sopranzi, N.; De Feo, G.; Mazzanti, G.; Tolu, L. (Biological and electroencephalographic parameters in rats in relation to Passiflora incarnata L). Clin. Ter., 1990, 132(5), 329-333.
[PMID: 2139836]
[49]
Boeira, J.M.; Fenner, R.; Betti, A.H.; Provensi, G.; Lacerda, L.A.; Barbosa, P.R.; González, F.H.; Corrêa, A.M.; Driemeier, D.; Dall’Alba, M.P.; Pedroso, A.P.; Gosmann, G.; da Silva, J.; Rates, S.M. Toxicity and genotoxicity evaluation of Passiflora alata Curtis (Passifloraceae). J. Ethnopharmacol., 2010, 128(2), 526-532.
[http://dx.doi.org/10.1016/j.jep.2009.09.037] [PMID: 19799991]
[50]
Farkas, S.; Berzsenyi, P.; Kárpáti, E.; Kocsis, P.; Tarnawa, I. Simple pharmacological test battery to assess efficacy and side effect profile of centrally acting muscle relaxant drugs. J. Pharmacol. Toxicol. Methods, 2005, 52(2), 264-273.
[http://dx.doi.org/10.1016/j.vascn.2004.11.005] [PMID: 16125625]
[51]
Diniz, T.C.; de Oliveira Júnior, R.G.; Miranda Bezerra Medeiros, M.A.; Gama, E. Silva, M.; de Andrade Teles, R.B.; Dos Passos Menezes, P.; de Sousa, B.M.H.; Abrahão Frank, L.; de Souza Araújo, A.A.; Russo Serafini, M.; Stanisçuaski Guterres, S.; Pereira Nunes, C.E.; Salvador, M.J.; da Silva Almeida, J.R.G. Anticonvulsant, sedative, anxiolytic and antidepressant activities of the essential oil of Annona vepretorum in mice: Involvement of GABAergic and serotonergic systems. Biomed. Pharmacother., 2019, 111, 1074-1087.
[http://dx.doi.org/10.1016/j.biopha.2018.12.114] [PMID: 30841421]
[52]
Alves, J.S.F.; Silva, A.M dos S.; da Silva, R.M.; Tiago, P.R.F.; de Carvalho, T.G. In vivo antidepressant effect of Passiflora edulis f. flavicarpa into cationic nanoparticles: Improving bioactivity and safety. Pharmaceutics, 2020, 12(4), 383.
[53]
Zibadi, S.; Watson, R.R. Passion Fruit (Passiflora edulis). Evidence-Based Integr Med., 2004, 1(3), 183-187.
[http://dx.doi.org/10.2165/01197065-200401030-00005]
[54]
Fisher, A.A.; Purcell, P.; Le Couteur, D.G. Toxicity of Passiflora incarnata L. J. Toxicol. Clin. Toxicol., 2000, 38(1), 63-66.
[http://dx.doi.org/10.1081/CLT-100100919] [PMID: 10696928]
[55]
Kliethermes, C.L.; Crabbe, J.C. Pharmacological and genetic influences on hole-board behaviors in mice. Pharmacol. Biochem. Behav., 2006, 85(1), 57-65.
[http://dx.doi.org/10.1016/j.pbb.2006.07.007] [PMID: 16949140]
[56]
Dhawan, K.; Dhawan, S.; Sharma, A. Passiflora: A review update. J. Ethnopharmacol., 2004, 94(1), 1-23.
[http://dx.doi.org/10.1016/j.jep.2004.02.023] [PMID: 15261959]
[57]
Grundmann, O.; Wähling, C.; Staiger, C.; Butterweck, V. Anxiolytic effects of a passion flower (Passiflora incarnata L.) extract in the elevated plus maze in mice. Pharmazie, 2009, 64(1), 63-64.
[PMID: 19216234]
[58]
de Castro, P.C.F.; Hoshino, A.; da Silva, J.C.; Mendes, F.R. Possible anxiolytic effect of two extracts of Passiflora quadrangularis L. in experimental models. Phytother. Res., 2007, 21(5), 481-484.
[http://dx.doi.org/10.1002/ptr.2079] [PMID: 17295387]
[59]
Valle, N.B.; Leite, J.R. Possíveis acoes psicotrópicas do maracujá (Passiflora edulis). Cienc. Cult., 1978(Suppl. 32), 211-215.
[60]
Müller, S.D. Vasconcelos, S.B.; Coelho, M.; Biavatti, M.W.L.C. LC and UV determination of flavonoids from Passiflora alata medicinal extracts and leaves. J. Pharm. Biomed. Anal., 2005, 37(2), 399-403.
[http://dx.doi.org/10.1016/j.jpba.2004.10.047] [PMID: 15708685]
[61]
Liao, Y-J.; Zhai, H-F.; Zhang, B.; Duan, T-X.; Huang, J-M. Anxiolytic and sedative effects of dehydroeffusol from Juncus effusus in mice. Planta Med., 2011, 77(5), 416-420.
[http://dx.doi.org/10.1055/s-0030-1250517] [PMID: 21104609]
[62]
Chen, X.; Broeyer, F.; de Kam, M.; Baas, J.; Cohen, A.; van Gerven, J. Pharmacodynamic response profiles of anxiolytic and sedative drugs. Br. J. Clin. Pharmacol., 2017, 83(5), 1028-1038.
[http://dx.doi.org/10.1111/bcp.13204] [PMID: 27922194]
[63]
Echeverry, S.M.; Medina, H.I.; Costa, G.M.; Aragón, D.M. Optimization of flavonoid extraction from Passiflora quadrangularis leaves with sedative activity and evaluation of its stability under stress conditions. Rev. Bras. Farmacogn., 2018, 28(5), 610-617.
[http://dx.doi.org/10.1016/j.bjp.2018.06.005]
[64]
Gazola, A.C.; Costa, G.M.; Zucolotto, S.M.; Castellanos, L.; Ramos, F.A.; de Lima, T.C.M.; Schenkel, E.P. The sedative activity of flavonoids from Passiflora quadrangularis is mediated through the GABAergic pathway. Biomed. Pharmacother., 2018, 100, 388-393.
[http://dx.doi.org/10.1016/j.biopha.2018.02.002] [PMID: 29454287]
[65]
Takeda, H.; Tsuji, M.; Matsumiya, T. Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice. Eur. J. Pharmacol., 1998, 350(1), 21-29.
[http://dx.doi.org/10.1016/S0014-2999(98)00223-4] [PMID: 9683010]
[66]
Kamei, J.; Ohsawa, M.; Tsuji, M.; Takeda, H.; Matsumiya, T. Modification of the effects of benzodiazepines on the exploratory behaviors of mice on a hole-board by diabetes. Jpn. J. Pharmacol., 2001, 86(1), 47-54.
[http://dx.doi.org/10.1254/jjp.86.47] [PMID: 11430472]
[67]
de Angelis, L.; Bertolissi, M.; Nardini, G.; Traversa, U.; Vertua, R. Interaction of caffeine with benzodiazepines: Behavioral effects in mice. Arch. Int. Pharmacodyn. Ther., 1982, 255(1), 89-102.
[PMID: 6122429]
[68]
Lister, R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl.), 1987, 92(2), 180-185.
[http://dx.doi.org/10.1007/BF00177912] [PMID: 3110839]
[69]
Sayin, U.; Purali, N.; Özkan, T.; Altug, T.; Büyükdevrim, S. Vigabatrin has an anxiolytic effect in the elevated plus-maze test of anxiety. Pharmacol. Biochem. Behav., 1992, 43(2), 529-535.
[http://dx.doi.org/10.1016/0091-3057(92)90188-L] [PMID: 1359580]
[70]
Lister, R.G. Ethologically-based animal models of anxiety disorders. Pharmacol. Ther., 1990, 46(3), 321-340.
[http://dx.doi.org/10.1016/0163-7258(90)90021-S] [PMID: 2188266]
[71]
Leite, M.P.; Fassin, J., Jr; Baziloni, E.M.F.; Almeida, R.N.; Mattei, R.; Leite, J.R. Behavioral effects of essential oil of Citrus aurantium L. inhalation in rats. Rev. Bras. Farmacogn., 2008, 18, 661-666.
[http://dx.doi.org/10.1590/S0102-695X2008000500003]
[72]
Jeon, S.; Lee, H-J.; Do, W.; Kim, H-K.; Kwon, J-Y.; Hwang, B.Y.; Yun, J. Randomized controlled trial assessing the effectiveness of midazolam premedication as an anxiolytic, analgesic, sedative, and hemodynamic stabilizer. Medicine (Baltimore), 2018, 97(35), e12187.
[http://dx.doi.org/10.1097/MD.0000000000012187] [PMID: 30170468]

Rights & Permissions Print Cite
Article Metrics
39
1
© 2024 Bentham Science Publishers | Privacy Policy